Futures Jump Ahead Of Tuesday Stimulus Deadline
CVS To Add 15,000 Workers To Meet Covid-19 Test Demand; Tigress Says Buy
Macro Briefing: 19 October 2020
Uber Seeks ‘Strategic Alternatives’ For Elevate Biz- Report
Brazil's Sao Paulo Pushes For Mandatory COVID Vaccinations
China Q3 GDP Disappoints, Retail Sales Signal Domestic Rebound Alive
To Vaccinate your portfolio or not?
Global coronavirus cases rise by one-day record of 400,000
GTT In $2.15B Deal To Sell Infrastructure Unit To I Squared; Shares Jump 7%
Goldman Sachs: 2 Stocks That Could Climb Over 90%
Fluidigm Soars 16% As Covid-19 Saliva Test Selected In US; Analyst Sees 78% Upside
First Citizens, CIT To Merge Into $100B US Regional Lender; Shares Spike
Eli Lilly To Snap Up Disarm In $135M Deal; Street Stays Bullish
Weekly Market Review: Quiet Ahead of Earnings Push
Halted Trials Raise New Safety Questions About 'Rushed' COVID-19 Vaccines
Macro Drivers
Paul Craig Roberts: Life Within The Matrix Is Our Future
Vaxart: An Alternative Opportunity in the COVID-19 Vaccine Landscape
US Close – Stocks bounce back on sales and sentiment data, Oil choppy on Libya concerns, Gold remains stuck
"The 6Ps Of 2020" And Where The Market Goes Next
University of Arkansas chemist to develop computational models of influenza virus protein
Week Ahead – Time running out for Trump
Goldman Sachs: Dump Dollars, Buy Silver
What coronavirus survey told us about getting people to take a vaccine
After years of shortages, Merck announces plans for a new factory for an old lifesaving drug
Dueling Townhalls Post Mortem: Snarling Savannah Vs Gentle George & Not A Single Question About Hunter Biden
Sanofi preps trials of second COVID-19 shot, as Russia approves another
Pfizer Plans To Apply For FDA's Emergency-Use Approval During Third Week Of November, CEO Says
Ignore the Vaccine Noise, Johnson & Johnson Is in Rude Health, Says Top Analyst
Peloton Set to Benefit from Structural Shift in Fitness Industry, Says 5-Star Analyst